AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9311477
Drug: No transfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No transfusion with portal infusion of chemotherapy
Trial: 2447687
Drug: Cimetidine 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 1,200 mg/day
Trial: 6092288
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg/day
Trial: 2802120
Drug: No H2-receptor
RxNorm normalized name: NO
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No H2-receptor antagonist (control)
Trial: 30179720
Drug: Teriparatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Teriparatide (20 μg daily from a month before surgery to 12 months after surgery)
Trial: 30179720
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (20 μg of teriparatide daily and 60 mg denosumab every 6 months)
Trial: 28316464
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of ropivacaine 1%
Trial: 28316464
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of ropivacaine 1%
Trial: 12844280
Drug: Conventional antipsychotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antipsychotics
Trial: 16832128
Drug: Polidocanol injections
RxNorm normalized name: Polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polidocanol injections in the area of neovascularization
Trial: 16832128
Drug: Lidocaine/epinephrine injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/epinephrine injections (control group)
Trial: 16832128
Drug: Polidocanol injections
RxNorm normalized name: Polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polidocanol injections (after crossover for control group)
Trial: 16832128
Drug: Polidocanol injections
RxNorm normalized name: Polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Polidocanol injections (treatment group)
Trial: 8889459
Drug: 3 x
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 x 3 mg oral pH-modified release budesonide (BUD)
Trial: 1894864
Drug: Angioplasty followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Angioplasty followed by a 30‐min intracoronary infusion of Fluosol at 40 ml/min
Trial: 6189412
Drug: Dextran 6%
RxNorm normalized name: Dextran 6%, Dextrose 5% Solution for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran 6% 500 ml
Trial: 27471039
Drug: Antioxidant and
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant and zinc supplements
Trial: 22111942
Drug: Lanreotide (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide (120 mg/month)
Trial: 20797478
Drug: Freeze-dried strawberry
RxNorm normalized name: BLACKBERRY MESOCARP FREEZE DRIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Freeze-dried strawberry beverage (50 g freeze-dried strawberries approximately 3 cups fresh strawberries)
Trial: 16879079
Drug: Cognitive‐behavioral therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐behavioral therapy and interpersonal psychotherapy
Trial: 16879079
Drug: Adjunctive sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive sleep interventions (suggested)
Trial: 16239176
Drug: Leisure-time physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leisure-time physical activity at midlife at least twice a week
Trial: 3767388
Drug: Betamethasone (B)
RxNorm normalized name: Betamethasone
DrugBank: Betamethasone phosphate (DB14669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Betamethasone (B) - 8 mg/body on day 1, 4 mg/body on days 2 and 3
Trial: 18450876
Drug: Behavioral therapy
RxNorm normalized name: RelieVRx Virtual Reality Behavioral Therapy for Pain Relief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral therapy with laxatives
Trial: 1288797
Drug: Implant-supported prosthesis
RxNorm normalized name: LARYNGEAL PROSTHESIS,PROVOX #8273
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implant-supported prosthesis
Trial: 9393430
Drug: Different implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different implant designs
Trial: 1288797
Drug: Different implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Different implant applications
Trial: 1288797
Drug: Individual implants
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual implants regarding jaw location
Trial: 1288797
Drug: Implant designs
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Implant designs
Trial: 29247636
Drug: Electronic-delivered screening,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic-delivered screening, brief intervention and referral to treatment
Trial: 29247636
Drug: Clinician-delivered screening,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinician-delivered screening, brief intervention and referral to treatment
Trial: 24582019
Drug: Group B
RxNorm normalized name: Blood group B IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group B (biofilm disclosing tablets)
Trial: 24582019
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (combination of A and B)
Trial: 22040450
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg oral midazolam
Trial: 20159176
Drug: Contraceptive patch
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive patch (Group A) delivering 20 mcg of EE and 150 mcg of norelgestromin
Trial: 20159176
Drug: Contraceptive vaginal
RxNorm normalized name: VCF 4% Contraceptive Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive vaginal ring (Group B) releasing 15 mcg of EE and 120 mcg of etonorgestrel
Trial: 18470901
Drug: 23-valent polysaccharide
RxNorm normalized name: pneumococcal 23-valent polysaccharide vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23-valent polysaccharide pneumococcal vaccine (PPV) alone
Trial: 20720342
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) training
Trial: 16174275
Drug: Systemic amoxicillin
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic amoxicillin and metronidazole (500 mg each, three times a day for 7 days)
Trial: 10094939
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) therapy for 4 years
Trial: 26948070
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose free fatty acid (FFA) suppositories
Trial: 26948070
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose free fatty acid (FFA) suppositories
Trial: 24831577
Drug: High-dose rosuvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose rosuvastatin
Trial: 15227611
Drug: Daptomycin (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daptomycin (4 mg/kg intravenously every 24 h for 7‐14 days)
Trial: 15227611
Drug: Conventional antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional antibiotics (penicillinase‐resistant penicillins or vancomycin)
Trial: 15227611
Drug: Daptomycin and
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin and Conventional antibiotics
Trial: 11092405
Drug: Nitroglycerin (NG)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NG) ointment applied to the skin once a day for 1 year
Trial: 11092405
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy (Premarin)
Trial: 9344303
Drug: Computer-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Computer-based treatment system
Trial: 3103338
Drug: EHDP 10
RxNorm normalized name: EHDP
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EHDP 10 mg/kg daily for 3 months
Trial: 3103338
Drug: EHDP 5
RxNorm normalized name: EHDP
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EHDP 5 mg/kg daily for 6 months
Trial: 3103338
Drug: EHDP 5
RxNorm normalized name: EHDP
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EHDP 5 mg/kg and 10 mg/kg
Trial: 3103338
Drug: Calcitonin (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcitonin (standard therapy)
Trial: 20842947
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone (5 g/L/d)
Trial: 20842947
Drug: Intratympanic dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intratympanic dexamethasone with other therapy
Trial: 20842947
Drug: Intratympanic methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic methylprednisolone with other therapy
Trial: 20842947
Drug: Intratympanic methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intratympanic methylprednisolone without other therapy
Trial: 9874127
Drug: Human leukocyte
RxNorm normalized name: Human leukocyte antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Human leukocyte interferon-alpha (2 x 10(6) IU/g) in hydrophilic gel (hydroxyethylcellulose, 1%)
Trial: 2237968
Drug: Active antithrombotic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antithrombotic therapy (warfarin or aspirin)
Trial: 104897
Drug: biguanide administration
RxNorm normalized name: biguanide
DrugBank: Biguanide (DB13100)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: biguanide administration
Trial: 22520250
Drug: Prasugrel 10
RxNorm normalized name: prasugrel 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel 10 mg daily
Trial: 25850030
Drug: Clopidogrel (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (150 mg daily for 6 days then 75 mg daily)
Trial: 22407658
Drug: β‐blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐blocker
Trial: 22407658
Drug: behavioral migraine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: behavioral migraine management + β‐blocker
Trial: 12050836
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg to 5 mg of intravenous morphine
Trial: 111288
Drug: 0.5 mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg, 1.5 mg, or 2.5 mg physostigmine i.v.
Trial: 111288
Drug: Oral choline
RxNorm normalized name: choline Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral choline chloride (8 g/day for 3 weeks or 16 g/day for 1 week)
Trial: 6360198
Drug: Heparin (10000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (10000 i.u. subcutaneously twice daily) throughout pregnancy and labour
Trial: 30667494
Drug: Web-based symptom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based symptom monitoring during chemotherapy
Trial: 26708301
Drug: Drospirenone-only pill
RxNorm normalized name: drospirenone Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone-only pill (4 mg) with scheduled 24-h delays in tablet intake
Trial: 26708301
Drug: Regular intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular intake of drospirenone-only pill
Trial: 21797805
Drug: Etanercept plus
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept plus nbUVB (50 mg once a week + nbUVB three times weekly for 4 weeks)
Trial: 21797805
Drug: Etanercept monotherapy
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept monotherapy (50 mg once a week)
Trial: 21797805
Drug: Etanercept monotherapy
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept monotherapy (for patients with high adherence)
Trial: 20864251
Drug: Intravesical botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical botulinum toxin type A (BoNTA) injection
Trial: 20864251
Drug: Intravesical botulinum
RxNorm normalized name: Clostridium botulinum
DrugBank: Clostridium botulinum (DB14223)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical botulinum toxin A (BoNTA) injection
Trial: 15781750
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg IV
Trial: 15781750
Drug: Fondaparinux 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 5.0 mg IV
Trial: 2651663
Drug: No local
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No local antibiotic therapy (group B)
Trial: 31937049
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine treatment including smoking quitting persuasion, vaccination, oxygen therapy and standardized medication)
Trial: 26506852
Drug: Placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (50 mg of cellulose)
Trial: 21439850
Drug: l-carnitine (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-carnitine (1,000 mg/day for 12 weeks)
Trial: 10934081
Drug: rPAF‐AH (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rPAF‐AH (1 mg/kg)
Trial: 19231487
Drug: rPAF‐AH (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rPAF‐AH (5 mg/kg)
Trial: 14871165
Drug: Wait-and-see policy
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wait-and-see policy vs Corticosteroid injections
Trial: 14871165
Drug: Physiotherapy vs
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physiotherapy vs Corticosteroid injections
Trial: 30623563
Drug: Lixisenatide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lixisenatide (10 μg subcutaneously)
Trial: 28700489
Drug: Dexmedetomidine (a
RxNorm normalized name: dexmedetomidine (as hydrochloride)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (a bolus dose of 0.5 μg/kg and then an infusion of 0.5 μg/kg/h)
Trial: 16384561
Drug: Simvastatin plus
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin plus L-carnitine (2g/day)
Trial: 20529243
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg/day)
Trial: 1358132
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of nilvadipine
Trial: 1358132
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg of nilvadipine
Trial: 22361711
Drug: Pozarevac area
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pozarevac area with mean Mg level of 42 mg L(‐1)
Trial: 22361711
Drug: Grocka area
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grocka area with mean Mg level of 11 mg L(‐1)
Trial: 20860504
Drug: Fondaparinux, 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux, 2.5 mg once daily for 45 days
Trial: 17971707
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (3 g twice daily)
Trial: 3314972
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser treatment with contiguous or overlapping laser spots
Trial: 3314972
Drug: Argon laser
RxNorm normalized name: argon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argon laser treatment at twice the minimum blanching power
Trial: 3314972
Drug: Neodymium (Nd)
RxNorm normalized name: Neodymium
DrugBank: Neodymium (DB15318)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neodymium (Nd) YAG laser treatment
Trial: 21956725
Drug: Clobazam 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam 0.5 mg/kg/day
Trial: 21956725
Drug: Clobazam 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam 0.25 mg/kg/day
Trial: 10335771
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors alone
Trial: 2751276
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC administered 0.5 h before enoxacin
Trial: 2751276
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC administered 2 h before enoxacin
Trial: 2751276
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC administered 8 h before enoxacin
Trial: 2751276
Drug: Maalox TC
RxNorm normalized name: Aluminum Hydroxide/Magnesium Hydroxide 225 MG/5 ML-200 MG/5 ML Oral Suspension [MAALOX TC]
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Maalox TC administered 2 h after enoxacin
Trial: 2751276
Drug: Ranitidine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine administered intravenously 2 h before enoxacin
Trial: 31188779
Drug: Rational-Emotive Behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rational-Emotive Behavior Therapy (REBT)
Trial: 28858362
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (18 g containing 300 mg CGA in 200 mL hot water)
Trial: 28858362
Drug: Decaffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Decaffeinated coffee (18 g containing 287 mg CGA in 200 mL hot water)
Trial: 19375519
Drug: Oral mesalamine
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral mesalamine 1 g twice daily
Trial: 16391575
Drug: Calcium (1
RxNorm normalized name: hydroxyapatite 275 mg calcium (1,100 mg) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1 g) and Vitamin D3 (800 IU) supplementation once daily for 1 year
Trial: 10842553
Drug: Daily iron/folate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily iron/folate supplement (60 mg iron/0.25 mg folate per day)
Trial: 10842553
Drug: Weekly iron/folate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron/folate supplement (120 mg iron/0.50 mg folate once a week)
Trial: 8518219
Drug: MPA (medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPA (medroxyprogesterone acetate) 500 mg i.m. daily for 28 days, then 500 mg i.m. twice weekly for 5 months
Trial: 8607407
Drug: Caffeine (3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3.3 mg/kg)
Trial: 29446548
Drug: 12-h combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-h combined physical and psychological treatment programme
Trial: 27530188
Drug: Ketoconazole 400
RxNorm normalized name: ketoconazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 400 mg once daily for 7 days, edoxaban on day 4
Trial: 27530188
Drug: Erythromycin 500
RxNorm normalized name: erythromycin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin 500 mg four times daily for 8 days, edoxaban on day 7
Trial: 27530188
Drug: Cyclosporine 500
RxNorm normalized name: Cyclosporine 500 microgram/mL eye suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine 500 mg single dose with edoxaban
Trial: 23286674
Drug: Education program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Education program via surface mail providing information on influenza vaccine effectiveness and safety (EPG)
Trial: 16336797
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue (10 ml) applied at the end of breast resection plus closed suction drains
Trial: 12827575
Drug: Thoracic epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracic epidural anesthesia with meperidine (TEA-M) (2 mg/kg in 10-12 mL) (n = 35)
Trial: 21412218
Drug: Alagebrium treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alagebrium treatment
Trial: 9177871
Drug: 0.75 microgram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.75 microgram of 1‐alpha‐hydroxyvitamin D3 with calcium (150 mg/day)